Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
358
datasets available to search
ShareScore release 0.9.0
Dataset results
358 results for “SAR studies”
Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study)
ClinicalTrials.gov study NCT04342182. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Study on Prevention of SARS-CoV-2 Transmission During a Large Indoor Gathering Event
ClinicalTrials.gov study NCT04872075. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)
ClinicalTrials.gov study NCT04383574. IPD Sharing: Not stated. Countries: 1. Publications: 3.
COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
ClinicalTrials.gov study NCT04290780. IPD Sharing: NO. Countries: 1. Publications: 2.
Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)
ClinicalTrials.gov study NCT05007951. IPD Sharing: Not stated. Countries: 6. Publications: 2.
This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
ClinicalTrials.gov study NCT00491504. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose.
ClinicalTrials.gov study NCT05463419. IPD Sharing: NO. Countries: 2. Publications: 1.
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
ClinicalTrials.gov study NCT05196932. IPD Sharing: NO. Countries: 1. Publications: 1.
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and I
ClinicalTrials.gov study NCT04369066. IPD Sharing: YES. Countries: 1. Publications: 1.
COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study
ClinicalTrials.gov study NCT04864548. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Participants Ages 12 Through 64 Years Considered at Higher Risk of Severe COVID-19, and Participant
ClinicalTrials.gov study NCT07069309. IPD Sharing: NO. Countries: 1. Publications: 0.
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
ClinicalTrials.gov study NCT04836793. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)
ClinicalTrials.gov study NCT04352608. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)
ClinicalTrials.gov study NCT05003466. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents
ClinicalTrials.gov study NCT04954287. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of Socio-demographic Factors, Behaviors and Practices Associated With Infection With SARS-CoV-2 Responsible for COVID-19
ClinicalTrials.gov study NCT04607941. IPD Sharing: NO. Countries: 1. Publications: 6.
Phase 3 Boosting Study for the SARS-CoV-2 rS Vaccine
ClinicalTrials.gov study NCT05249816. IPD Sharing: NO. Countries: 1. Publications: 6.
Vienna Versus SARS-CoV-2 Virus Study
ClinicalTrials.gov study NCT04407429. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19
ClinicalTrials.gov study NCT05102643. IPD Sharing: NO. Countries: 1. Publications: 16.
Efficacy and Safety Study of Nitazoxanide (NTX) in the Treatment of Patients With SARS-CoV-2 Virus Infection (COVID-19)
ClinicalTrials.gov study NCT04463264. IPD Sharing: NO. Countries: 1. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.